Schedule 13D ownership disclosure
AVEO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 053588109
Event date: 2016-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 29.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000809
- Form type
- SC 13D
- Filer
- AVEO PHARMACEUTICALS, INC.
- CIK
- CIK 1325879
- Filed
- May 31, 2016
- Reporting period
- May 18, 2016
- Description
- Schedule 13D beneficial ownership